Literature DB >> 29250236

Post-Ictal Transient Atrial Fibrillation As A Rare Manifestation Of Grand Mal Seizure.

Gulshan Man Singh Dangol1,2, David A Hoffman1,2.   

Abstract

Atrial fibrillation (AF) most frequently occurs as a consequence of multiple etiologies including valvular disease, coronary artery disease, hyperthyroidism, alcohol ingestion, and pulmonary embolism. However, on rare occasion transient AF may be a result of generalized tonic-clonic seizures (GTCS). A 33-year-old-man presented to the emergency department following GTCS in AF with rapid ventricular response. He had no previous documented history. Diagnostic evaluation including electrolytes, thyroid function, cardiac enzymes, serum and urine drug screen, and two-dimensional echocardiogram were unremarkable. Diltiazem was initiated for rate control with spontaneous conversion to sinus rhythm with no recurrence. AF post-seizure is a rare phenomenon but should be considered in epileptic patients. Anticoagulation must be considered in AF due to the risk of cardioembolic stroke but should be weighed against the potential risk of head injury and subsequent intracranial bleed in patients with grand mal seizures.

Entities:  

Keywords:  Anticoagulation; Atrial fibrillation; Seizures

Year:  2017        PMID: 29250236      PMCID: PMC5673295          DOI: 10.4022/jafib.1643

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  12 in total

1.  Use of the CHA(2)DS(2)-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation.

Authors:  Deirdre A Lane; Gregory Y H Lip
Journal:  Circulation       Date:  2012-08-14       Impact factor: 29.690

2.  Atrial fibrillation associated with epileptic seizures--reply.

Authors:  Moshe Herskovitz; Yitzhak Schiller
Journal:  JAMA Neurol       Date:  2013-02       Impact factor: 18.302

3.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

4.  Peri-ictal prolonged atrial fibrillation after generalized seizures: description of a case and etiopathological considerations.

Authors:  Marcella Vedovello; Filippo Baldacci; Angelo Nuti; Gabriele Cipriani; Martina Ulivi; Andrea Vergallo; Paolo Borelli
Journal:  Epilepsy Behav       Date:  2012-02-16       Impact factor: 2.937

5.  Prolonged atrial fibrillation following generalized tonic-clonic seizures.

Authors:  Rainer Surges; Susanna Moskau; Bettina Viebahn; Jan-Christoph Schoene-Bake; Joerg O Schwab; Christian E Elger
Journal:  Seizure       Date:  2012-06-12       Impact factor: 3.184

6.  The ictal bradycardia syndrome: localization and lateralization.

Authors:  Jeffrey W Britton; Gena R Ghearing; Eduardo E Benarroch; Gregory D Cascino
Journal:  Epilepsia       Date:  2006-04       Impact factor: 5.864

7.  Changes in plasma catecholamines after tonic-clonic seizures.

Authors:  R P Simon; M J Aminoff; N L Benowitz
Journal:  Neurology       Date:  1984-02       Impact factor: 9.910

8.  Prolonged atrial fibrillation precipitated by new-onset seizures and marijuana abuse.

Authors:  Dinesh Singh; Margaret Huntwork; Varun Shetty; Gina Sequeira; Olugbenga Akingbola
Journal:  Pediatrics       Date:  2014-01-13       Impact factor: 7.124

9.  EEG and ECG in sudden unexplained death in epilepsy.

Authors:  Maromi Nei; Reginald T Ho; Bassel W Abou-Khalil; Frank W Drislane; Joyce Liporace; Alicia Romeo; Michael R Sperling
Journal:  Epilepsia       Date:  2004-04       Impact factor: 5.864

10.  Cardiac arrhythmias in focal epilepsy: a prospective long-term study.

Authors:  Fergus J Rugg-Gunn; Robert J Simister; Mark Squirrell; Diana R Holdright; John S Duncan
Journal:  Lancet       Date:  2004 Dec 18-31       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.